Where does Chemocentryx, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Chemocentryx, Inc. ranks #2,836 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Chemocentryx, Inc. hold?

Chemocentryx, Inc. holds 135 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Chemocentryx, Inc.'s Innovation Score?

Chemocentryx, Inc. has an Innovation Score of 45.6 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Chemocentryx, Inc.'s patent grant rate increasing or decreasing?

Chemocentryx, Inc.'s recent grant velocity is +69% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Chemocentryx, Inc.'s patents?

Chemocentryx, Inc.'s patents average 18.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Chemocentryx, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Chemocentryx, Inc.

Q: What technology areas does Chemocentryx, Inc. focus on?

Chemocentryx, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 124 patents. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 135 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Chemocentryx ranks #2,836 of 49,997 tracked US assignees by granted-patent volume, with 135 patents across 11 technology areas.

#2,836
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.6/100): 18.3
avg claims per patent: +69%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2836 · US Corporation #2,836 · 135 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 135 grants
TOP-DECILE #2,836/49,997
PHOTO-FINISH Baylor University
CPC-FOCUS A61P · 11 areas
INNOV-PAR 45.6/100
CLAIMS-RICH 18.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +69% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Baylor University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Chemocentryx · this assignee

46
Control Components · near

46
Frank's International · near

46
HÜBNER & KG · near

46
Whelen Engineering · near

46
3D Lighting… · lowest

7

What this shows Chemocentryx's Innovation Score is 45.6/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Chemocentryx's grants concentrate

Chemocentryx, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 91.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (20 grants) versus a trough of 4 in 2018. By volume, Chemocentryx sits between Syracuse University and Inalfa Roof Systems Group B.V..

Chemocentryx's three-year grant acceleration

From 2019–2021 to 2022–2024, Chemocentryx, Inc. moved from 53 to 47 grants (0.89x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,528. See the growth leaderboard.

Syracuse Universi…

136
Sion Power

136
Taiho Pharmaceuti…

136
Baylor University

135
Forum US

135
Freni Brembo S P A

135
Geodynamics

135
Inalfa Roof Syste…

135
Chemocentryx ◀

135

What this shows Chemocentryx holds 135 patents at rank #2,836, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Chemocentryx

By rank, the assignees closest to #2,836 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Chemocentryx's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Chemocentryx, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Frank's International, LLC 46 Whelen Engineering Company, Inc. 46 HÜBNER GmbH & Co. KG 46 Control Components, Inc. 46

Similar claim depth

Nearest assignees by average claims per patent (18.3 here).

Elbit Systems Ltd. 18.3 avg Dura Operating, LLC 18.3 avg Datalogic IP Tech S.R.L. 18.3 avg Mentor Graphics Corporation 18.3 avg

Chemocentryx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Chemocentryx, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	5.9%
2016	7	5.2%
2017	13	9.6%
2018	4	3.0%
2019	17	12.6%
2020	20	14.8%
2021	16	11.9%
2022	18	13.3%
2023	17	12.6%
2024	12	8.9%
2025partial year	3	2.2%

Which technologies does Chemocentryx, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 124

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 107

C07D - Heterocyclic Compounds 101

C07K - Peptides 13

Y02A - Technologies FOR Adaptation TO Climate Change 11

C07C - Acyclic OR Carbocyclic Compounds 11

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 11

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 10

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 11 of 11 technology areas

Where it ranks

Overall rank by patents

#2,836

of 49,997 tracked assignees

Innovation Score

45.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Chemocentryx, Inc.'s patent record in context - here's where to go next.

Chemocentryx, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 91.9% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #2,836 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Chemocentryx, Inc. against Syracuse University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.